ProQR Therapeutics N.V. Stock
ProQR Therapeutics N.V. Stock
A very strong showing by ProQR Therapeutics N.V. today, with an increase of €0.071 (3.920%) compared to yesterday's price.
ProQR Therapeutics N.V. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 2 € there is a slightly positive potential of 8.34% for ProQR Therapeutics N.V. compared to the current price of 1.85 €.
Our community identified positive and negative aspects for ProQR Therapeutics N.V. stock for the coming years. 6 users see the criterium "Worthwhile Investment for the next years" as a plus for the ProQR Therapeutics N.V. stock. On the other hand our users think that "Company culture" could be a problem in the future.
Pros and Cons of ProQR Therapeutics N.V. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ProQR Therapeutics N.V. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | 3.920% | -2.431% | -5.816% | -7.096% | 3.128% | -64.500% | - |
| Pharming Group | 1.890% | 0.618% | -10.896% | -11.860% | -13.645% | -15.955% | 8.942% |
| Salarius Pharmaceuticals Inc. | -2.830% | -5.069% | 5.641% | -71.389% | -25.766% | -98.474% | -99.994% |
| Ardelyx Inc. | 5.440% | 7.123% | -7.526% | 58.693% | 9.273% | 3.541% | - |
Comments
The comment is under review
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc. from $1.80 to $2.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PRQR provided by MarketBeat